Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post-and pre-capillary pulmonary hypertension (Cpc-PH)

Authors
Category Primary study
ConferenceEuropean Journal of Heart Failure
Year 2017
This article has no abstract
Epistemonikos ID: e1982c364dbd6a576b80c3b1c736242412a74053
First added on: Apr 29, 2026